545 related articles for article (PubMed ID: 16251197)
1. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
Morlon A; Munnich A; Smahi A
Hum Mol Genet; 2005 Dec; 14(23):3751-7. PubMed ID: 16251197
[TBL] [Abstract][Full Text] [Related]
2. Mutations in EDARADD account for a small proportion of hypohidrotic ectodermal dysplasia cases.
Chassaing N; Cluzeau C; Bal E; Guigue P; Vincent MC; Viot G; Ginisty D; Munnich A; Smahi A; Calvas P
Br J Dermatol; 2010 May; 162(5):1044-8. PubMed ID: 20222921
[TBL] [Abstract][Full Text] [Related]
3. Functional studies for the TRAF6 mutation associated with hypohidrotic ectodermal dysplasia.
Fujikawa H; Farooq M; Fujimoto A; Ito M; Shimomura Y
Br J Dermatol; 2013 Mar; 168(3):629-33. PubMed ID: 22924441
[TBL] [Abstract][Full Text] [Related]
4. The Ectodysplasin and NFkappaB signalling pathways in odontogenesis.
Courtney JM; Blackburn J; Sharpe PT
Arch Oral Biol; 2005 Feb; 50(2):159-63. PubMed ID: 15721144
[TBL] [Abstract][Full Text] [Related]
5. Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD locus.
Bal E; Baala L; Cluzeau C; El Kerch F; Ouldim K; Hadj-Rabia S; Bodemer C; Munnich A; Courtois G; Sefiani A; Smahi A
Hum Mutat; 2007 Jul; 28(7):703-9. PubMed ID: 17354266
[TBL] [Abstract][Full Text] [Related]
6. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling.
Ishitani T; Takaesu G; Ninomiya-Tsuji J; Shibuya H; Gaynor RB; Matsumoto K
EMBO J; 2003 Dec; 22(23):6277-88. PubMed ID: 14633987
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
8. NUMBL interacts with TAB2 and inhibits TNFalpha and IL-1beta-induced NF-kappaB activation.
Ma Q; Zhou L; Shi H; Huo K
Cell Signal; 2008 Jun; 20(6):1044-51. PubMed ID: 18299187
[TBL] [Abstract][Full Text] [Related]
9. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.
Mizukami J; Takaesu G; Akatsuka H; Sakurai H; Ninomiya-Tsuji J; Matsumoto K; Sakurai N
Mol Cell Biol; 2002 Feb; 22(4):992-1000. PubMed ID: 11809792
[TBL] [Abstract][Full Text] [Related]
10. A missense mutation in the death domain of EDAR abolishes the interaction with EDARADD and underlies hypohidrotic ectodermal dysplasia.
Masui Y; Farooq M; Sato N; Fujimoto A; Fujikawa H; Ito M; Shimomura Y
Dermatology; 2011; 223(1):74-9. PubMed ID: 21876339
[TBL] [Abstract][Full Text] [Related]
11. Signaling and subcellular localization of the TNF receptor Edar.
Koppinen P; Pispa J; Laurikkala J; Thesleff I; Mikkola ML
Exp Cell Res; 2001 Oct; 269(2):180-92. PubMed ID: 11570810
[TBL] [Abstract][Full Text] [Related]
12. Edar and Troy signalling pathways act redundantly to regulate initiation of hair follicle development.
Pispa J; Pummila M; Barker PA; Thesleff I; Mikkola ML
Hum Mol Genet; 2008 Nov; 17(21):3380-91. PubMed ID: 18689798
[TBL] [Abstract][Full Text] [Related]
13. Ectodysplasin receptor-mediated signaling is essential for embryonic submandibular salivary gland development.
Jaskoll T; Zhou YM; Trump G; Melnick M
Anat Rec A Discov Mol Cell Evol Biol; 2003 Apr; 271(2):322-31. PubMed ID: 12629675
[TBL] [Abstract][Full Text] [Related]
14. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
15. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
[TBL] [Abstract][Full Text] [Related]
16. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.
Ninomiya-Tsuji J; Kishimoto K; Hiyama A; Inoue J; Cao Z; Matsumoto K
Nature; 1999 Mar; 398(6724):252-6. PubMed ID: 10094049
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
18. TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway.
Kishida S; Sanjo H; Akira S; Matsumoto K; Ninomiya-Tsuji J
Genes Cells; 2005 May; 10(5):447-54. PubMed ID: 15836773
[TBL] [Abstract][Full Text] [Related]
19. Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes.
Ear T; Fortin CF; Simard FA; McDonald PP
J Immunol; 2010 Apr; 184(7):3897-906. PubMed ID: 20200282
[TBL] [Abstract][Full Text] [Related]
20. [New genes candidates for ectodermal dysplasia: TAB2, TRAF6 and TAK1].
Morlon A; Smahi A; Munnich A
Med Sci (Paris); 2006 Mar; 22(3):229-30. PubMed ID: 16527194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
